management of febrile infants and young children

Upload: sdb10c

Post on 04-Jun-2018

222 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 Management of Febrile Infants and Young Children

    1/48

    Management of the Febrile Infant

    and Young Child

    Benjamin P. Harrison, MD, LTC, MC, USA

    Program Director, Madigan-University of WashingtonEmergency Medicine Residency

    *Revised from previous edition by Ann Egland, MD and Kim Forman, MD

    Government Services Chapter

    American College of Emergency Physicians

  • 8/13/2019 Management of Febrile Infants and Young Children

    2/48

    GSACEP 2005

    Scope of the Problem

    Fever = Temp > 100.4 F or 38.0 C (some

    use 100.5 or greater)

    10-20% of all pediatric visits to the ER.

    20% will have fever without source

  • 8/13/2019 Management of Febrile Infants and Young Children

    3/48

    GSACEP 2005

    Approach to the

    Febrile Infant / Child

    The Great Debate

    Approaches in the 1 month36 month old

    febrile infant/child vary greatly

    Guidelines change as disease prevalence

    fluctuates; data/studies conflict at times

    Grey Areas are abundant; be open to change!One-size-fits-all approach discouraged

  • 8/13/2019 Management of Febrile Infants and Young Children

    4/48

    GSACEP 2005

    Occult Bacteremia

    Transient bacteremia is a daily occurrence

    (tooth brushing, dental or bowel

    procedures)

    Identifying occult bacteremia increases with

    increasing fever, WBC, and ANC.

    Vast majority of infants/children with fever

    are viral, even if hyperpyrexic

  • 8/13/2019 Management of Febrile Infants and Young Children

    5/48

    GSACEP 2005

    Occult Bacteremia

    2-3% of febrile children < 3 y.o. had occult

    bacteremia in past (H. influenza B and S

    pneumoniae predominately)

    Numbers much lower now

    OPB = occur pneumococcal bacteremia

    SBI = serious bacterial infection

  • 8/13/2019 Management of Febrile Infants and Young Children

    6/48

    GSACEP 2005

    Occult Bacteremia

    By definition, a well-appearing child with

    bacteria in his/her blood.

    Initially bacteremia occult or hidden

    May progress to toxicity, septic shock or

    produce focal infections

  • 8/13/2019 Management of Febrile Infants and Young Children

    7/48

    GSACEP 2005

    Incidence of Occult Bacteremia (Post HiBand Pre Pneumococcal Vaccine Era)

    1.9% incidence of bacteremia

    82.9% S. pneumoniae13 times more likely to be pathogen (vs.

    contaminant) if grew in less than 18 hrs.

    95.7% resolved without parenteralantibiotics

  • 8/13/2019 Management of Febrile Infants and Young Children

    8/48

    GSACEP 2005

    Predictors of Occult Bacteremia

    Age Dependent

    Premature InfantsInfants and children

    Birth to 28 days

    28-60 days 2 to 36 months

    Above 3 years

  • 8/13/2019 Management of Febrile Infants and Young Children

    9/48

    GSACEP 2005

    Predictors of Occult Bacteremia

    OPB pts younger, ill-appearing, with

    higher temperatures, WBC, ANC, and ABC

    Occult bacteremia in 8.1% with ANC

    >10,000 vs. 0.8% if ANC

  • 8/13/2019 Management of Febrile Infants and Young Children

    10/48

    GSACEP 2005

    Predictors of Occult Bacteremia

    When a recognizable viral syndrome

    present, low risk for occult bacteremia.

    i.e. Croup, varicella, bronchiolitis,

    stomatitis

    0.2% rate of occult bacteremiaBlood cultures are not indicated in these

    cases

  • 8/13/2019 Management of Febrile Infants and Young Children

    11/48

    GSACEP 2005

    Occult Urinary Tract Infections

    Occult UTIs 4% of boys < 12 mos and 9% of

    girls < 24 mos (Not immunized against E. coli !)

    Uncircumcised males more at risk

    UA & urine culture < 6 months for circumcised

    and < 12 months old in uncircumcised

    Get UA in hyperpyrexia even if other sourcespresent (AOM, AGE, etc)

  • 8/13/2019 Management of Febrile Infants and Young Children

    12/48

    GSACEP 2005

    Occult UTI Diagnosis

    Urine Culture > 103-105 cfus = gold std

    Tr. LE, > 10 WBC/hpf and neg- Gm stain or

    no bacteria are all highly senstitive

    Nit +, >Mod LE, + Gm Stain, > 10

    WBC/hpf and bacteruria are all very

    specific for UTI on cath UA

  • 8/13/2019 Management of Febrile Infants and Young Children

    13/48

    GSACEP 2005

    Occult Urinary Tract Infection

    75% of febrile UTIs are pyelonephritis

    Consequences of missed pyelonephritis in

    childhood

    Renal scarring in 27-64% (with risk of HTN,

    renal failure and pre-eclampsia as an adult)

    13-15% of end-stage renal disease is thought tobe related to under-treated childhood UTI.

  • 8/13/2019 Management of Febrile Infants and Young Children

    14/48

    GSACEP 2005

    Occult Pneumonia

    40% of children suspected of pneumonia

    confirmed with CXR

    26% without pneumonia clinically had

    positive CXR in subgroup with WBC >

    20,000

    Strongly consider CXR in children < 5 y.o.

    with WBC > 15K even if normal RR, pulse Ox

    and lung exam!

  • 8/13/2019 Management of Febrile Infants and Young Children

    15/48

    GSACEP 2005

    Consequences of Missing OPB

    10-25% of children with OPB will

    develop cellulitis, pneumonia, or sepsis

    if not treated

    3-6% will develop meningitis (Pre

    Prevnar) Much lower numbers now

  • 8/13/2019 Management of Febrile Infants and Young Children

    16/48

    GSACEP 2005

    Why Not Treat All Highly Febrile

    Children with Antibiotics?

    Indiscriminate use of antibioticscontributes to emerging resistance of S.

    pneumoniae

    Adverse drug reactions

    Decreases patient discomfort and EDcosts

  • 8/13/2019 Management of Febrile Infants and Young Children

    17/48

    GSACEP 2005

    The Febrile Child

    Rectal temperature is the gold standard

    Age > 36 months much less at risk

    Definition of fever for selective protocols to

    be discussed are as follows:

    Birth to 28 days

    29-90 days

    3-36 months

  • 8/13/2019 Management of Febrile Infants and Young Children

    18/48

    GSACEP 2005

    What about the Temperature?

    Recent immunization history

    Overbundling is not the cause of a fever

    Accept the T-max at home

    Parents good at identifying fever (tactile)

    Normal/low temp doesnt preclude SBI

  • 8/13/2019 Management of Febrile Infants and Young Children

    19/48

    GSACEP 2005

    Toxic Appearing?

    Eval toxic-appearing children immediately

    Septic workup and admit, regardless of age

    Toxicity is defined as:

    Lethargy

    Signs of poor perfusion

    Hypoventilation, hyperventilation, or cyanosis

    I.E. Shock / sepsis / meningitis / encephalitis

  • 8/13/2019 Management of Febrile Infants and Young Children

    20/48

    GSACEP 2005

    Approach to the Toxic Patient

    Fever alone may make a child appear ill

    Ask about childs behavior when not febrile

    and observe in ED if afebrile

    Normal?

    Still ill appearing?

    Eating/drinking?

  • 8/13/2019 Management of Febrile Infants and Young Children

    21/48

    GSACEP 2005

    Vital Signs

    Fifth Vital Sign

    Pulse Ox mandatory with abnormal lung

    exam, resp rate or respiratory symptoms

    RR will increase with fever

    Pulse oximetry more reliable predictor infection

    than respiratory rate

  • 8/13/2019 Management of Febrile Infants and Young Children

    22/48

    GSACEP 2005

    Vital signs

    Address Abnormal Vital Signs

    Get accurate weight for treatment

    Elevated pulse may be from fever or crying

    Repeat pulse after antipyretics or hydration

    Try to document vitals when patient is calm

  • 8/13/2019 Management of Febrile Infants and Young Children

    23/48

    GSACEP 2005

    Physical Exam Findings

    Petechial / purpuric rashes (invasive

    bacteremia)

    Toxic appearance and WBC >15,000 are

    100% sensitivity for identification these

    rashes

    Meningococcemia associated with purpura

    more than petechiae alone.

  • 8/13/2019 Management of Febrile Infants and Young Children

    24/48

    GSACEP 2005

    Birth to 28 Days Old

    Documented temperature above 100.4

    degrees F requires a full septic work-

    up and admission

  • 8/13/2019 Management of Febrile Infants and Young Children

    25/48

    GSACEP 2005

    Birth to 28 Days Old

    Septic work-up includes:

    CBC with manual differential

    Blood culture

    Urinalysis and urine culture

    CXR

    LP for CSF analysis and culture; Herpes PCRTesting

    Stool culture and fecal WBCs for diarrhea

  • 8/13/2019 Management of Febrile Infants and Young Children

    26/48

    GSACEP 2005

    Birth to 28 Days Old

    If ill-appearing, give parenteral antibiotics

    once urine/blood obtained ( < 30 mins &

    before LP !)

    Ampicillin 50-100 mg/kg/dose IV +

    Cefotaxime 50 mg/kg/dose IV up to 2g

    OR Ampicillin + Gentamicin 2.5 mg/kg IV

  • 8/13/2019 Management of Febrile Infants and Young Children

    27/48

    GSACEP 2005

    Nontoxic 28 to 90 Days Old

    Various approaches and debatable area

    10% will have aseptic meningitis if LP done

    Management also depends on risk factors

    Low Risk Group may be discharged home

    High Risk Group requires more extensive

    workup and admission

  • 8/13/2019 Management of Febrile Infants and Young Children

    28/48

    GSACEP 2005

    28 to 90 Days Old

    Low Risk Patients

    No bacterial focus on PE (excluding OM)

    Non-toxic, previously healthy

    Not hospitalized, term infant , no antibiotics

    Reliable parents with car/phone, close F/U

  • 8/13/2019 Management of Febrile Infants and Young Children

    29/48

    GSACEP 2005

    28 to 90 Days Old

    Low Risk Patients

    WBC 5-15k (

  • 8/13/2019 Management of Febrile Infants and Young Children

    30/48

    GSACEP 2005

    Nontoxic 28 to 90 Days Old

    Most conservative approach

    Full Septic Workup

    Antibiotics within 30 minutes of arrival

    Ceftriaxone 100 mg/kg o.k. after 6 weeks age

    Admit pending culture results

    Consider Acyclovir treatment if Herpes

    PCR testing not returned yet and CSF

    results not clearly bacterial in etiology

  • 8/13/2019 Management of Febrile Infants and Young Children

    31/48

    GSACEP 2005

    Nontoxic 28 to 90 Days Old

    The Minimalist approach

    UA, Blood and Urine cultures

    1 in 1,000 missed meningitis (most viral) if

    no LPparents/provider o.k. with that risk?

    No antibiotics

    Follow up visit in 24 hours

  • 8/13/2019 Management of Febrile Infants and Young Children

    32/48

    GSACEP 2005

    Nontoxic 28 to 90 Days Old

    My Approach

    Lab/CXR work-up for fever >38 degrees C /100.4 degrees F, observe patient in ED

    No antibiotics if no LP and Close F/Uensured

    LP added if:

    Younger patient (2860 days) with high feverIll, but non-toxic, appearing or any other

    concern while observing

  • 8/13/2019 Management of Febrile Infants and Young Children

    33/48

    GSACEP 2005

  • 8/13/2019 Management of Febrile Infants and Young Children

    34/48

    GSACEP 2005

    Toxic 3 to 36 Months Old

    Toxic appearing? Concern for sepsis or

    meningitis?

    Treat empirically

    Ceftriaxone 100 mg/kg IV up to 4G OR

    Vancomycin 15 mg/kg IV up to 500 mg AND

    Cefotaxime 50 mg/kg IV up to 2G

  • 8/13/2019 Management of Febrile Infants and Young Children

    35/48

    GSACEP 2005

    3 to 36 Months Old

    Well appearing with clear source of fever:

    Treat and send home with follow-up

    Patient has a source but appears toxic:

    LP, antibiotics and admit

    Well appearing but no clear source of fever;

    Debatable approachdepends on

    immunization status

  • 8/13/2019 Management of Febrile Infants and Young Children

    36/48

    GSACEP 2005

    Why Treat in

    Pre-HiB and Pre-Prevnar Era?

    Patients who received oral antibiotics later

    identified with OPB had fewer serious

    bacterial infections (3.3% vs. 9.7%).

    Meningitis developed in 0.8% vs. 2.7%,

    respectively.

    h ld

  • 8/13/2019 Management of Febrile Infants and Young Children

    37/48

    GSACEP 2005

    Nontoxic 3 to 36 Months Old

    Not Immunized

    < 24 months old with 39 C (102.2 F) fever

    without a identifiable source needs further

    work-up

    24-36 months old, 39.5 C (103 F) used

    because risk of bacteremia increases to2.1% from 0.7% with fever 39 C to 39.4 C.

    d

  • 8/13/2019 Management of Febrile Infants and Young Children

    38/48

    GSACEP 2005

    Nontoxic Un-immunized

    3 to 36 Months Old

    Labs recommended in those without a

    source:

    Blood culture

    CBC

    Cath U/A and urine culture (as indicated)

    CXR for tachypnea, retractions, focalabnormalities, room air SaO2 < 95%

  • 8/13/2019 Management of Febrile Infants and Young Children

    39/48

    GSACEP 2005

    N i U i i d

  • 8/13/2019 Management of Febrile Infants and Young Children

    40/48

    GSACEP 2005

    Nontoxic Un-immunized

    3 to 36 Months Old

    If urine or CXR is positive, treat with appropriate

    antibiotics for UTI or pneumonia

    If ANC > 10k (or WBC > 15k), send blood culturethen give ceftriaxone 50 mg/kg IV/IM

    Follow-up with ED or PCM in 24 hours to check

    culture results, reassess the patient and consider

    need for further antibiotic treatment.

  • 8/13/2019 Management of Febrile Infants and Young Children

    41/48

    N i I i d*

  • 8/13/2019 Management of Febrile Infants and Young Children

    42/48

    GSACEP 2005

    Nontoxic Immunized*

    3 to 36 Months Old

    > 95% infants with serotype specific

    antibodies after 2 doses Prevnar

    Herd immunity / lower invasive disease

    After 2 doses HiB and Prevnar vaccines,

    UTI alone is primary concern if no source

    * At least 2 doses each of HiB and

    Pneumococcal vaccines

  • 8/13/2019 Management of Febrile Infants and Young Children

    43/48

    GSACEP 2005

    3 to 36 Months Old

    Advise parents/caretakers to return

    immediately if the child is worse

    Follow-up in the appropriate clinic/PCM

    office if not improving or for culture results

  • 8/13/2019 Management of Febrile Infants and Young Children

    44/48

    GSACEP 2005

    3 Years Old and Up

    After a careful history and physical to

    identify possible fever causes, treatment

    should be tailored to specific causes only.

    In the well-appearing child without a

    source, no further evaluation is indicated.

    Occult serious bacterial infection in childrenover 3 years is extremely low.

  • 8/13/2019 Management of Febrile Infants and Young Children

    45/48

    GSACEP 2005

    3 Years Old and Up

    Treat fever with anti-pyretics:

    Acetaminophen 15- 20 mg/kg every 4 hours

    and/or Ibuprofen 10 mg/kg every 6-8 hours

    Advise parents to return immediately if the

    child is worse and to follow-up with his/her

    PCM if not improving.

  • 8/13/2019 Management of Febrile Infants and Young Children

    46/48

    GSACEP 2005

    Special Cases

    Any child with a complicated or significant

    medical history should be treated

    conservatively.

    Clinical judgment must be used.

    Febrile children with sickle cell disease

    under age 4 are usually admitted.

  • 8/13/2019 Management of Febrile Infants and Young Children

    47/48

    GSACEP 2005

    Summary

    Treatment of the febrile infant and young

    child depends on:

    Appearance

    Fever

    Age

    Past Medical History

    Immunization Status

  • 8/13/2019 Management of Febrile Infants and Young Children

    48/48

    Summary

    Bloodwork rarely helpful

    Do complete History and PE

    Ensure appropriate admission

    Arrange close F/U or return to ED

    Always tell the parents to return if the childis getting worse!